This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knobloch, J.
Right arrow Articles by Rüther, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knobloch, J.
Right arrow Articles by Rüther, U.

Next Article 

Molecular and Cellular Biology, January 2008, p. 529-538, Vol. 28, No. 2
0270-7306/08/$08.00+0     doi:10.1128/MCB.00533-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Thalidomide Induces Limb Anomalies by PTEN Stabilization, Akt Suppression, and Stimulation of Caspase-Dependent Cell Death{triangledown}

Jürgen Knobloch,1* Ingo Schmitz,2 Katrin Götz,1 Klaus Schulze-Osthoff,2 and Ulrich Rüther1

Institute for Animal Developmental and Molecular Biology,1 Institute of Molecular Medicine, Heinrich Heine University, D-40225 Düsseldorf, Germany2

Received 29 March 2007/ Returned for modification 19 June 2007/ Accepted 30 October 2007

Thalidomide, a drug used for the treatment of multiple myeloma and inflammatory diseases, is also a teratogen that causes birth defects, such as limb truncations and microphthalmia, in humans. Thalidomide-induced limb truncations result from increased cell death during embryonic limb development and consequential disturbance of limb outgrowth. Here we demonstrate in primary human embryonic cells and in the chicken embryo that thalidomide-induced signaling through bone morphogenetic proteins (Bmps) protects active PTEN from proteasomal degradation, resulting in suppression of Akt signaling. As a consequence, caspase-dependent cell death is stimulated by the intrinsic and Fas death receptor apoptotic pathway. Most importantly, thalidomide-induced limb deformities and microphthalmia in chicken embryos could be rescued by a pharmacological PTEN inhibitor as well as by insulin, a stimulant of Akt signaling. We therefore conclude that perturbation of PTEN/Akt signaling and stimulation of caspase activity is central to the teratogenic effects of thalidomide.

* Corresponding author. Present address: University of Cologne, Medical Clinic III, Department of Pneumology, Kerpener Strasse 62, D-50924 Cologne, Germany. Phone: 49-221-4784191. Fax: 49-221-47887031. E-mail: juergen.knobloch{at}uk-koeln.de

{triangledown} Published ahead of print on 26 November 2007.

Molecular and Cellular Biology, January 2008, p. 529-538, Vol. 28, No. 2
0270-7306/08/$08.00+0     doi:10.1128/MCB.00533-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Wells, P. G., McCallum, G. P., Chen, C. S., Henderson, J. T., Lee, C. J. J., Perstin, J., Preston, T. J., Wiley, M. J., Wong, A. W. (2009). Oxidative Stress in Developmental Origins of Disease: Teratogenesis, Neurodevelopmental Deficits, and Cancer. Toxicol Sci 108: 4-18 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»